使用药物基因组学来个性化药物治疗:哪些药物,何时以及如何
Sophie L Stocker1,2,3,4,5, Thomas M Polasek1,2,3,4,5
1School of Pharmacy, Faculty of Medicine and Health, The University of Sydney.
药物基因组测试分析基因变异以个性化药物治疗,识别患有不良药物反应或治疗失败风险的患者. 结果需要临床背景才能准确解释.
科学领域:
- 药物基因组学 药物基因组学
- 临床药理学 临床药理学
- 遗传学 遗传学 是一个
背景情况:
- 药物基因组测试提供了对影响药物代谢和反应的患者特异性基因变异的见解.
- 它有助于定制药物治疗以提高疗效和安全性.
- 了解对药物作用的遗传影响对于个性化医学至关重要.
研究的目的:
- 突出药基因组测试在临床决策中的作用.
- 解释药物基因组数据如何预测和澄清药物反应和不良事件.
- 讨论医疗保险折扣的药物基因组测试的现状.
主要方法:
- 药物治疗中的药物基因组测试应用的审查.
- 鉴定特定的基因药物关联 (例如,TPMT,HLA-B*57:01).
- 临床实用性的分析和药物基因组学结果的解释.
主要成果:
- 药基因组测试可以识别患有严重药物不良反应或治疗失败风险增加的患者.
- 测试可以阐明意外的药物反应或缺乏疗效.
- 目前的医疗保险折扣适用于TPMT和HLA-B*57:01测试.
结论:
- 药基因组测试是个性化药物治疗的一个有价值的工具.
- 测试结果必须在患者的临床背景下进行解释.
- 虽然一些测试得到了折扣,但其他测试尽管有建议,但缺乏医疗保险覆盖.
更多相关视频
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Analysis of Population Pharmacokinetic Data
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
